Literature DB >> 20132875

Characterization and stability of solid dispersions based on PEG/polymer blends.

Heike Bley1, Bernd Fussnegger, Roland Bodmeier.   

Abstract

Solid dispersions were prepared by a melting method from the water-insoluble model drugs carbamazepine and nifedipine and polyethylene glycol 1500 (PEG 1500) or 1:1 mixtures of PEG 1500 and the polymers polyvinylpyrrolidone (PVP 30, PVP 12), polyvinylpyrrolidone-co-vinylacetate (PVPVA) and Eudragit EPO (Eudragit) in order to combine advantages of the different carrier polymers (recrystallization inhibition, processability and stability). The solid dispersions were characterized by dissolution, powder X-ray diffractometry and microscopy directly after preparation and after storage for 3 and 6 months at 25 degrees C/0% relative humidity (RH) or 3 months at 40 degrees C/75% RH. More than 80% drugs were released from all solid dispersions within 20min. The dissolution rate of carbamazepine decreased in the order of PEG 1500>PEG 1500/Eudragit>PEG 1500/PVP 30>PEG 1500/PVPVA>PEG 1500/PVP 12. The dissolution rank order was not directly correlated to the amorphous/crystalline state of the drugs, but rather to the properties of the PEG 1500/polymer compositions. Nifedipine was released in the order of PEG 1500>PEG 1500/PVPVA>PEG 1500/PVP 30>PEG 1500/PVP 12>PEG 1500/Eudragit. Amorphous nifedipine was present in all PEG 1500/polymer dispersions except in pure PEG 1500 solid dispersion. The significant increase in dissolution rate of PEG 1500 solid dispersions was due to the reduced crystallinity of the drug and the excellent solubilisation properties of PEG 1500. After 6 months storage at 25 degrees C/0% RH, the solid dispersions released both drugs in the order PEG 1500/PVPVA>PEG 1500/PVP 30>PEG 1500/PVP 12>PEG 1500/Eudragit>PEG 1500. The stabilized amorphous state of the drug resulted in stable dissolution profiles of PEG 1500/PVPVA, PEG 1500/PVP 30 and PEG 1500/PVP 12 when compared to the PEG 1500 solid dispersions, which contained a higher amount of crystalline drug. The solid dispersions with PEG 1500/PVPVA or PEG 1500/PVP stored for 3 months at 40 degrees C/75% RH showed phase separation due to the hygroscopic properties of the polymers. The influence of 10% (w/w) of the solubilisers polyoxyl 40 hydrogenated castor oil (Cremophor), macrogol-15-hydroxystearate (Solutol) and fatty alcohol alkoxylate (Pluronic) on the dissolution rate and the physical state of the drug was significant. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20132875     DOI: 10.1016/j.ijpharm.2010.01.039

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  23 in total

Review 1.  Amorphous solid dispersion technique for improved drug delivery: basics to clinical applications.

Authors:  Dinesh Kumar Mishra; Vinod Dhote; Arpit Bhargava; Dinesh Kumar Jain; Pradyumna Kumar Mishra
Journal:  Drug Deliv Transl Res       Date:  2015-12       Impact factor: 4.617

2.  Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2).

Authors:  Chris Brough; Dave A Miller; Daniel Ellenberger; Dieter Lubda; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2016-02-10       Impact factor: 3.246

3.  Molecular interaction studies of amorphous solid dispersions of the antimelanoma agent betulinic acid.

Authors:  Meiki Yu; Joseph E Ocando; Louis Trombetta; Parnali Chatterjee
Journal:  AAPS PharmSciTech       Date:  2014-10-18       Impact factor: 3.246

4.  Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.

Authors:  Sanjay Verma; Varma S Rudraraju
Journal:  AAPS PharmSciTech       Date:  2015-02-12       Impact factor: 3.246

5.  Disintegration mediated controlled release supersaturating solid dispersion formulation of an insoluble drug: design, development, optimization, and in vitro evaluation.

Authors:  Sanjay Verma; Varma S Rudraraju
Journal:  AAPS PharmSciTech       Date:  2014-09-05       Impact factor: 3.246

6.  Improved dissolution and anti-inflammatory effect of ibuprofen by solid dispersion.

Authors:  Liyuan Chen; Qifeng Dang; Chengsheng Liu; Jun Chen; Lei Song; Xiguang Chen
Journal:  Front Med       Date:  2012-05-09       Impact factor: 4.592

Review 7.  Peptide-Modified Biopolymers for Biomedical Applications.

Authors:  Jessica Hersh; David Broyles; José Manuel Condor Capcha; Emre Dikici; Lina A Shehadeh; Sylvia Daunert; Sapna Deo
Journal:  ACS Appl Bio Mater       Date:  2020-12-24

8.  Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.

Authors:  Yan-rong Jiang; Zhen-hai Zhang; Qi-yuan Liu; Shao-ying Hu; Xiao-yun Chen; Xiao-bin Jia
Journal:  Int J Nanomedicine       Date:  2013-06-25

9.  Preparation of carboxymethylchitosan nanoparticles with Acid-sensitive bond based on solid dispersion of 10-hydroxycamptothecin.

Authors:  Risheng Yao; Lu Liu; Shengsong Deng; Weitao Ren
Journal:  ISRN Pharm       Date:  2011-07-27

10.  Dissolution enhancement of efavirenz by solid dispersion and PEGylation techniques.

Authors:  B Bindu Madhavi; B Kusum; Ch Krishna Chatanya; M Naga Madhu; V Sri Harsha; David Banji
Journal:  Int J Pharm Investig       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.